| Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates A Carattoli, G Arcari, G Bibbolino, F Sacco, D Tomolillo, FM Di Lella, ... Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 00574-21, 2021 | 67 | 2021 |
| Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital G Arcari, G Raponi, F Sacco, G Bibbolino, FM Di Lella, F Alessandri, ... International journal of antimicrobial agents 57 (1), 106245, 2020 | 65 | 2020 |
| Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones G Arcari, A Carattoli Pathogens and Global Health 117 (4), 328-341, 2023 | 56 | 2023 |
| Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae–Producing KPC-31, a D179Y … G Tiseo, M Falcone, A Leonildi, C Giordano, S Barnini, G Arcari, ... Open Forum Infectious Diseases 8 (6), ofab141, 2021 | 46 | 2021 |
| Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020–21 M Falcone, G Tiseo, G Arcari, A Leonildi, C Giordano, S Tempini, ... Journal of Antimicrobial Chemotherapy 77 (4), 1140-1145, 2022 | 40 | 2022 |
| Clinical impact of COVID-19 on multi-drug-resistant gram-negative bacilli bloodstream infections in an intensive care unit setting: two pandemics compared F Cogliati Dezza, G Arcari, F Alessi, S Valeri, A Curtolo, F Sacco, ... Antibiotics 11 (7), 926, 2022 | 28 | 2022 |
| A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid … G Arcari, FM Di Lella, G Bibbolino, F Mengoni, M Beccaccioli, G Antonelli, ... Antimicrobial Agents and Chemotherapy 64 (4), 10.1128/aac. 02435-19, 2020 | 25 | 2020 |
| Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019 G Bibbolino, FM Di Lella, A Oliva, M Lichtner, C Del Borgo, G Raponi, ... Diagnostic Microbiology and Infectious Disease 100 (4), 115399, 2021 | 17 | 2021 |
| Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality P Pasculli, MA Zingaropoli, GM Masci, L Mazzuti, V Perri, F Paribeni, ... New Microbiol 44 (3), 145-54, 2021 | 15 | 2021 |
| Genotypic evolution of Klebsiella pneumoniae sequence type 512 during ceftazidime/avibactam, meropenem/vaborbactam, and cefiderocol treatment, Italy G Arcari, F Cecilia, A Oliva, R Polani, G Raponi, F Sacco, A De Francesco, ... Emerging Infectious Diseases 29 (11), 2266, 2023 | 12 | 2023 |
| Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report G Arcari, A Oliva, F Sacco, FM Di Lella, G Raponi, D Tomolillo, A Curtolo, ... European Journal of Clinical Microbiology & Infectious Diseases 41 (3), 495-500, 2022 | 12 | 2022 |
| Corynebacterium ramonii sp. nov., a novel toxigenic member of the Corynebacterium diphtheriae species complex C Crestani, G Arcari, A Landier, V Passet, D Garnier, S Brémont, ... Research in Microbiology 174 (7), 104113, 2023 | 11 | 2023 |
| Genome-Based Retrospective Analysis of a Providencia stuartii Outbreak in Rome, Italy: Broad Spectrum IncC Plasmids Spread the NDM Carbapenemase within … V Capitani, G Arcari, A Oliva, F Sacco, G Menichincheri, L Fenske, ... Antibiotics 12 (5), 943, 2023 | 11 | 2023 |
| Virulence plasmid pINV as a genetic signature for Shigella flexneri phylogeny G Pilla, G Arcari, CM Tang, A Carattoli Microbial Genomics 8 (6), 000846, 2022 | 11 | 2022 |
| Corynebacteria of the diphtheriae Species Complex in Companion Animals: Clinical and Microbiological Characterization of 64 Cases from France K Museux, G Arcari, G Rodrigo, M Hennart, E Badell, J Toubiana, S Brisse Microbiology Spectrum 11 (3), e00006-23, 2023 | 10 | 2023 |
| Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing … A Oliva, D Al Ismail, G Arcari, MC Miele, E Casali, F Sacco, L Volpicelli, ... Journal of Global Antimicrobial Resistance 33, 321-327, 2023 | 9 | 2023 |
| Genetic background of neomycin resistance in clinical Escherichia coli isolated from Danish pig farms P Subramani, G Menichincheri, M Pirolo, G Arcari, E Kudirkiene, R Polani, ... Applied and Environmental Microbiology 89 (10), e00559-23, 2023 | 7 | 2023 |
| Multidrug-resistant toxigenic Corynebacterium diphtheriae sublineage 453 with two novel resistance genomic islands G Arcari, M Hennart, E Badell, S Brisse Microbial Genomics 9 (1), 000923, 2023 | 7 | 2023 |
| In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains A Bressan, DM Rodio, F Stangherlin, G Puggioni, C Ambrosi, G Arcari, ... Journal of Global Antimicrobial Resistance 20, 328-331, 2020 | 7 | 2020 |
| Beyond appearance: An unusual manifestation of isolated oral secondary syphilis E Mari, M Nudo, E Palese, L Cotticelli, C Cotticelli, G Zino, R Coppola, ... International Journal of Immunopathology and Pharmacology 33, 2058738419845566, 2019 | 6 | 2019 |
